When PersImmune approached us in May 2019, they were looking to expand their media presence to promote the successes of their clinical trial towards two goals; to expand patient enrollment in their clinical trial, and develop new scientific and investment partnerships. The challenge was in how to highlight the important distinctions between their new technology and other immunotherapy approaches. touchGrove was engaged to develop a website, technical videos, medical renderings and animations, a social media presence, and press and investor outreach.